Kyan Younes, Emily Johns, Christina B Young, Gabriel Kennedy, Shubhabrata Mukherjee, Hillary A Vossler, Joseph Winer, Karly Cody, Victor W Henderson, Kathleen L Poston, Tobey J Betthauser, Bill Bevis, William M Brooks, Jeffrey M Burns, Stephen A Coombes, Charles DeCarli, Frank P DiFilippo, Ranjan Duara, Audrey P Fan, Laura E Gibbons, Todd Golde, Sterling C Johnson, Rebecca J Lepping, James Leverenz, Sean McDougall, Emily Rogalski, Elizabeth Sanders, Joshua Pasaye, Jaiashre Sridhar, Andrew J Saykin, Anjali Sridharan, Russell Swerdlow, Emily H Trittschuh, David Vaillancourt, Eric Vidoni, Wei-En Wang, Jesse Mez, Timothy J Hohman, Duygu Tosun, Sarah Biber, Walter A Kukull, Paul K Crane, Elizabeth C Mormino
INTRODUCTION: Amyloid positron emission tomography (PET) is increasingly available for diagnosis of Alzheimer`s disease (AD); however, its practical implications in heterogenous cohorts are debated.
